# Hypertonic Saline Therapy in Ambulatory Heart Failure Unit.

Study · id `cardio:ct-nct04533997` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04533997](<https://clinicaltrials.gov/study/NCT04533997>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04533997

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 167 participants.

## Technical summary

Registry record NCT04533997. Randomized; quadruple masking; primary purpose treatment. Start 2021-01-01 (actual); primary completion 2023-05-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 167 participants (enrolled count; ClinicalTrials.gov record NCT04533997, source copy `cardio:ctgov-nct04533997-2023-11-09`, retrieved 2026-10-26)
- Started: 2021-01-01 (actual) (ClinicalTrials.gov record NCT04533997, source copy `cardio:ctgov-nct04533997-2023-11-09`, retrieved 2026-10-26)
- Primary completion: 2023-05-10 (actual) (ClinicalTrials.gov record NCT04533997, source copy `cardio:ctgov-nct04533997-2023-11-09`, retrieved 2026-10-26)
- Completion: 2023-09-30 (actual) (ClinicalTrials.gov record NCT04533997, source copy `cardio:ctgov-nct04533997-2023-11-09`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT04533997, source copy `cardio:ctgov-nct04533997-2023-11-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04533997-2023-11-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Hypertonic Saline Therapy in Ambulatory Heart Failure Unit.
- Condition: Heart Failure
- Intervention (Drug): Hypertonic saline solution plus intravenous furosemide
- Intervention (Drug): Intravenous furosemide
- Lead sponsor: Puerta de Hierro University Hospital
- Lead sponsor class: OTHER
- Collaborator: Instituto de Salud Carlos III
- Collaborator class: OTHER\_GOV
- Collaborator: Spanish Society of Cardiology
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Puerta de Hierro University Hospital (`cardio:org-puerta-de-hierro-university-hospital`)
- Registry lists this organization as a collaborator: Instituto de Salud Carlos III (`cardio:org-instituto-de-salud-carlos-iii`)
- Registry lists this organization as a collaborator: Spanish Society of Cardiology (`cardio:org-spanish-society-of-cardiology`)

## Provenance

Content hash: a9e32f690cfe3695de08286dd26ba14ed401219f67c95399a5df620395ef62a1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
